
浏览全部资源
扫码关注微信
纸质出版:2012
移动端阅览
高兰英,刘增长,考国营.凝集素样氧化型低密度脂蛋白受体-1在C反应蛋白诱导人脐静脉内皮细胞组织因子表达中的作用[J].陆军军医大学学报(原第三军医大学学报),2012,34(15):1538-1542.
Gao Lanying,Liu Zengzhang,Kao Guoying.Role of LOX-1 on tissue factor expression in human umbilical vein endothelial cells induced by C-reactive protein[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(15):1538-1542.
高兰英,刘增长,考国营.凝集素样氧化型低密度脂蛋白受体-1在C反应蛋白诱导人脐静脉内皮细胞组织因子表达中的作用[J].陆军军医大学学报(原第三军医大学学报),2012,34(15):1538-1542. DOI:
Gao Lanying,Liu Zengzhang,Kao Guoying.Role of LOX-1 on tissue factor expression in human umbilical vein endothelial cells induced by C-reactive protein[J].J Amry Med Univ (J Third Mil Med Univ),2012,34(15):1538-1542. DOI:
目的 研究凝集素样氧化型低密度脂蛋白受体-1(lectin-type oxidized LDL receptor1,LOX-1)在C-反应蛋白(c-reactive protein,CRP)诱导人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)组织因子(tissue factor,TF)表达中的作用。 方法 用人重组质粒pTracer CMV2-CRP转染HUVECs细胞,分正常对照组、空质粒GFP组和CRP-GFP组(n=3),RT-PCR、Western blot检测TF、LOX-1 mRNA和蛋白表达。Western blot检测各组P-ERK1/2、T-ERK1/2、P-JNK、T-JNK蛋白表达。CRP-GFP组分别加LOX-1阻断剂、ERK1/2阻断剂(U0126)、JNK阻断剂(SP600125),Western blot检测TF蛋白。 结果 用表达人CRP的质粒转染HUVECs显著增加LOX-1 mRNA和蛋白表达[(0.70±0.03) vs (0.24±0.01),(0.661 6±0.020 0) vs (0.255 8±0.040 0),P0.05]、TF的mRNA和蛋白表达[(0.442±0.040) vs (0.146 0±0.030 0),(0.727 4±0.020 0)vs(0.217 4±0.020 0),P0.05]。CRP启动了ERK1/2 MAPK,未启动JNK MAPK。CRP上调 TF表达被ERK1/2阻断剂而非JNK阻断剂阻断.抗LOX-1的中和抗体显著减少CRP诱导的TF mRNA和蛋白表达[(0.264 0±0.030 0) vs (0.442 0±0.040 0),(0.324 4±0.040 0) vs (0.727 4±0.020 0),P0.05]。 结论 CRP诱导HUVECs细胞LOX-1表达上调,并通过LOX-1受体这一新途径上调TF表达,且CRP通过ERK1/2 MAPK信号途径非JNK MAPK途径上调了HUVEC细胞TF的表达。
Objective To investigate the effect of lectin-type oxidized LDL receptor 1(LOX-1)on the expression of tissue factor (TF) induced by C-reactive protein (CRP) in human umbilical vein endothelial cells(HUVECs). Methods HUVECs were transfected the recombination plasmid pTracer CMV2-CRP. The cells were divided into a normal control group
GFP group and CRP-GFP group. RT-PCR was used to detect the mRNA of TF and LOX-1
and Western blotting was used to detect the protein expression of LOX-1
TF
ERK1/2 and JNK respectively. After HUVECs transfected with CRP-GFP were treated with ERK1/2 inhibitor (U0126) or JNK inhibitor (SP600125) respectively
the expression of TF gene was detected by RT-PCR and Western blotting. Results CRP transfection into human HUVECs resulted in significantly increase in the expression of LOX-1 at mRNA and protein levels (0.70±0.03 vs 0.24±0.01
0.661 6±0.020 0 vs 0.255 8±0.040 0
P0.05) and the expression of TF (0.442±0.040 vs 0.146 0±0.030 0
0.727 4±0.020 0 vs 0.217 4±0.020 0
P0.05). CRP activated ERK1/2
but not JNK MAP kinase (MAPK)
and the effect of CRP on TF expression was blocked by pharmacological inhibitor of ERK1/2 (U0126)
but not JNK (SP600125) MAPK. Neutralizing antibody to LOX-1 significantly attenuated the mRNA and protein expression of TF induced by CRP (0.264 0±0.030 0 vs 0.442 0±0.040 0
0.324 4±0.040 0 vs 0.727 4±0.020 0
P0.05). Conclusion CRP enhances LOX-1 expression in HUVECs and thus promotes TF expression through LOX-1 receptor
by a underlying mechanism of ERK1/2 MAPK but not JNK MAPK pathway.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621